NO951462L - Preparation based on polyoxyethylene-polyoxypropylene block copolymers and container containing the preparation - Google Patents
Preparation based on polyoxyethylene-polyoxypropylene block copolymers and container containing the preparationInfo
- Publication number
- NO951462L NO951462L NO951462A NO951462A NO951462L NO 951462 L NO951462 L NO 951462L NO 951462 A NO951462 A NO 951462A NO 951462 A NO951462 A NO 951462A NO 951462 L NO951462 L NO 951462L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- container containing
- polyoxyethylene
- block copolymers
- polyoxypropylene block
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Packages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Forseglet farmasøytisk akseptabel beholder som i et vakuum eller i en inert atmosfære inneholder en steril vandig injiserbar oppløsning av en blokkopo- lymer av polyoksypropylen/polyoksyetylen, idet oppløsningen er vesentlig fri for antioksydasjonsmiddel og er buffret ved en pH-verdi fra 5,5 til 6,5.Sealed pharmaceutically acceptable container containing, in a vacuum or inert atmosphere, a sterile aqueous injectable solution of a polyoxypropylene / polyoxyethylene block copolymer, the solution being substantially free of antioxidant and buffered at a pH of 5.5 to 6 .5.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929221883A GB9221883D0 (en) | 1992-10-19 | 1992-10-19 | Novel formulation |
PCT/GB1993/002141 WO1994008596A1 (en) | 1992-10-19 | 1993-10-18 | Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it |
Publications (2)
Publication Number | Publication Date |
---|---|
NO951462D0 NO951462D0 (en) | 1995-04-18 |
NO951462L true NO951462L (en) | 1995-06-13 |
Family
ID=10723654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO951462A NO951462L (en) | 1992-10-19 | 1995-04-18 | Preparation based on polyoxyethylene-polyoxypropylene block copolymers and container containing the preparation |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0671919A1 (en) |
JP (1) | JPH08502284A (en) |
KR (1) | KR950703345A (en) |
AU (1) | AU674895B2 (en) |
BR (1) | BR9307268A (en) |
CA (1) | CA2147889A1 (en) |
CZ (1) | CZ63395A3 (en) |
GB (1) | GB9221883D0 (en) |
HU (1) | HUT75701A (en) |
IL (1) | IL107313A0 (en) |
MX (1) | MX9306467A (en) |
NO (1) | NO951462L (en) |
NZ (1) | NZ256890A (en) |
PL (1) | PL308459A1 (en) |
SI (1) | SI9300545A (en) |
SK (1) | SK44795A3 (en) |
TW (1) | TW276183B (en) |
WO (1) | WO1994008596A1 (en) |
ZA (1) | ZA937714B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2185162A4 (en) * | 2007-08-10 | 2012-04-25 | Synthrx Inc | Polymer therapy for the treatment of chronic microvascular diseases |
CA2927361A1 (en) | 2013-10-16 | 2015-04-23 | Mast Therapeutics, Inc. | Diuretic induced alterations of plasma volume |
US9757411B2 (en) | 2014-07-07 | 2017-09-12 | Aires Pharmaceuticals, Inc. | Poloxamer therapy for heart failure |
EP3747448A1 (en) | 2014-07-07 | 2020-12-09 | LifeRaft Biosciences, Inc. | A poloxamer composition free of long circulating material and methods for production and uses thereof |
WO2016007542A1 (en) | 2014-07-07 | 2016-01-14 | Mast Therapeutics, Inc. | Poloxamer therapy for heart failure |
CN109432511A (en) * | 2018-12-29 | 2019-03-08 | 常州乐奥医疗科技股份有限公司 | A kind of temperature-sensitive hydrogel and its preparation method and application |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3641240A (en) * | 1968-09-27 | 1972-02-08 | Wyandotte Chemicals Corp | Method for the treatment of an embolus or thrombus |
DE3234084A1 (en) * | 1982-09-14 | 1984-03-15 | B. Braun Melsungen Ag, 3508 Melsungen | PHARMACEUTICAL PREPARATIONS FOR TREATING UNWANTED GROWTHS AND THEIR USE |
US4879109A (en) * | 1986-05-15 | 1989-11-07 | Emory University | Method for treating burns |
US4938961A (en) * | 1989-04-28 | 1990-07-03 | Geoffrey Collins | Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia |
-
1992
- 1992-10-19 GB GB929221883A patent/GB9221883D0/en active Pending
-
1993
- 1993-10-18 WO PCT/GB1993/002141 patent/WO1994008596A1/en not_active Application Discontinuation
- 1993-10-18 SK SK447-95A patent/SK44795A3/en unknown
- 1993-10-18 CA CA002147889A patent/CA2147889A1/en not_active Abandoned
- 1993-10-18 SI SI9300545A patent/SI9300545A/en unknown
- 1993-10-18 AU AU52842/93A patent/AU674895B2/en not_active Expired - Fee Related
- 1993-10-18 PL PL93308459A patent/PL308459A1/en unknown
- 1993-10-18 NZ NZ256890A patent/NZ256890A/en unknown
- 1993-10-18 HU HU9501104A patent/HUT75701A/en unknown
- 1993-10-18 MX MX9306467A patent/MX9306467A/en unknown
- 1993-10-18 KR KR1019950701458A patent/KR950703345A/en not_active Application Discontinuation
- 1993-10-18 EP EP93923008A patent/EP0671919A1/en not_active Withdrawn
- 1993-10-18 ZA ZA937714A patent/ZA937714B/en unknown
- 1993-10-18 IL IL107313A patent/IL107313A0/en unknown
- 1993-10-18 CZ CZ95633A patent/CZ63395A3/en unknown
- 1993-10-18 BR BR9307268A patent/BR9307268A/en not_active Application Discontinuation
- 1993-10-18 TW TW082108706A patent/TW276183B/zh active
- 1993-10-18 JP JP6509782A patent/JPH08502284A/en active Pending
-
1995
- 1995-04-18 NO NO951462A patent/NO951462L/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL107313A0 (en) | 1994-01-25 |
TW276183B (en) | 1996-05-21 |
SK44795A3 (en) | 1996-05-08 |
KR950703345A (en) | 1995-09-20 |
CA2147889A1 (en) | 1994-04-28 |
CZ63395A3 (en) | 1995-07-12 |
HUT75701A (en) | 1997-05-28 |
NZ256890A (en) | 1995-10-26 |
WO1994008596A1 (en) | 1994-04-28 |
EP0671919A1 (en) | 1995-09-20 |
PL308459A1 (en) | 1995-07-24 |
MX9306467A (en) | 1994-05-31 |
HU9501104D0 (en) | 1995-06-28 |
ZA937714B (en) | 1995-04-18 |
GB9221883D0 (en) | 1992-12-02 |
AU5284293A (en) | 1994-05-09 |
JPH08502284A (en) | 1996-03-12 |
NO951462D0 (en) | 1995-04-18 |
BR9307268A (en) | 1999-05-11 |
SI9300545A (en) | 1994-06-30 |
AU674895B2 (en) | 1997-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7549696A (en) | Bioadhesive pharmaceutical composition for the controlled release of active principles | |
AU7640787A (en) | Apparatus for enhancing cell growth, preservation and transport | |
IT8125835A0 (en) | COFFEE PACKAGE IN EVACUATED ATMOSPHERE OR INERT GAS. | |
CA2121046A1 (en) | Method of Delivering Paging Messages Using Voice Mail | |
AU4089189A (en) | The use of asymmetric membranes in delivery devices | |
ES2101001T3 (en) | PROPYLENE POLYMERS AND COPOLYMERS GRAFTED WITH VINYLPOLYBUTADIENE AND ITS PREPARATION PROCEDURE. | |
AU2170788A (en) | Eva based multi-layer, heat shrinkable, packaging film and bags made therefrom | |
ES551459A0 (en) | PRESSURE DEVICE FOR STACKING A SHEET OF SHEETS OR SHEETS | |
IE873125L (en) | Benzimidazole derivatives | |
ATE176577T1 (en) | PRESERVATIVES | |
NO951462L (en) | Preparation based on polyoxyethylene-polyoxypropylene block copolymers and container containing the preparation | |
TW327602B (en) | A pharmaceutical composition of an ophthalmic suspension containing difluprednate | |
CA2023419A1 (en) | Vacuum track and pallets | |
DK404589A (en) | VACUUM PACKAGED DRAFT PRODUCT AND PROCEDURE FOR PACKAGING PACKAGING | |
AU4434189A (en) | An anti-human immunodeficiency virus composition | |
KR910021375A (en) | Crystalline salt of 4- (di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz [cd] indole | |
AU4429885A (en) | Solid medicament formulations containing dihydropyridines | |
DK0517160T3 (en) | Ophthalmic extended release preparations | |
AU8332791A (en) | Oral pharmaceutical compositions containing melatonin | |
AU6788687A (en) | A pharmaceutical which can be administered nasally, a process for its preparation, and its use | |
AU6452190A (en) | A process for the preparation of 3-(l-pyroglutamyl)-l- thiazolidine-4-carboxylic acid and its derivatives | |
AU2234588A (en) | Administration of extremely low dosages of dideoxynucleoside analogs for treating or preventing AIDS in subjects | |
IT1260469B (en) | BOXING MACHINE FOR VIALS IN PARTICULAR OF THE GLASS TYPE FOR MEDICAL USE | |
ZA973794B (en) | Antioxidant medicament. | |
EP1038800B8 (en) | Packaging of framed or unframed mirror |